NCT02881294

A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-G3031 in Healthy Subjects

A Phase I, Single-center, Open-label, Single-dose Study to Evaluate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of Orally Administered SUVN-G3031 in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Suven Life Sciences Limited · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is to investigate the effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-G3031 in Healthy Subjects

Conditions

• Cognitive Disorders

Interventions

Type	Name	Description
DRUG	SUVN-G3031

Timeline

• Start date: 2016-08-01
• Primary completion: 2017-09-01
• Completion: 2017-09-01
• First posted: 2016-08-26
• Last updated: 2017-09-25

Locations

1 site across 1 country: United States